Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
Published 28 July 2009, doi:10.1136/bmj.b3050
Cite this as: BMJ 2009;339:b3050
Julius Wagner-Jauregg won the Nobel prize in 1927 for developing an effective treatment for syphilis which entailed deliberately infecting patients with malaria. This research suggests that fever may be a beneficial response to infection. The 2007 guideline from the National Institute for Health and Clinical Excellence (NICE) on feverish illness in children under 5 reviewed the sparse evidence on using antipyretic medicines, which seems to indicate that artificially lowering a fever may reduce the immune response and prolong illness. NICE therefore recommended, "Do not routinely give antipyretic drugs to a child with fever with the sole aim of reducing body temperature."1
A small trial on the use of antipyretics in an intensive care unit was stopped because mortality was 16% in the treated group and 1% in the untreated group.2
The existing evidence suggests that antipyretics should be avoided in patients with pandemic flu,3 yet the Health Protection Agency (HPA) continues to recommend their routine use.4 We urgently need more research into the potential harmful effects of antipyretic medicines. When will the large scale randomised controlled trials be done?
Cite this as: BMJ 2009;339:b3050
Gina Johnson, general practitioner1
1 National Minor Illness Centre, Luton LU2 7HR
johgina{at}gmail.com
Read all Rapid Responses